Clinical Trials
48 trialsA Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer
IRCCS San Raffaele
High-resolution Intra-operative PSMA PET-CT in Prostate Cancer
IRCCS San Raffaele
TRAP-PAIN
Kayseri Education and Research Hospital
PROMET-BR
AstraZeneca
FOLLOW-UP
Imperial College London
BALANCE
Institute of Cancer Research, United Kingdom
CHAS3
Insel Gruppe AG, University Hospital Bern
PULSE
Novartis
18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients
Assiut University
UroDNA
Institut Cancerologie de l'Ouest
PRIAPUS-PCa
CancerCare Manitoba
PROSTest_STRAT
Wren Laboratories LLC
VAPOR-LTR
Francis Medical Inc.
CLEAR-PC
Universidad Miguel Hernandez de Elche
TransPRIDE
Queen Mary University of London
SEQ-bpMRI
Peking University First Hospital
INCLUDE PC
Royal Marsden NHS Foundation Trust
Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer
Anhui Medical University
Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy
Konkuk University Medical Center
Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer
Shanghai Changzheng Hospital
RWS-GU001
Shanghai Pudong New Area Gongli Hospital
ultraHART
Jena University Hospital
PREDICT
Gold Standard Phantoms
MASS-ADT
Guy's and St Thomas' NHS Foundation Trust
PROSPEX
Ankara University
LODE
Ente Ospedaliero Ospedali Galliera
LOCUS
AstraZeneca
PREduKiné
Centre Hospitalier de Roubaix
Focal Laser Ablation in Prostate Cancer
Ain Shams University
Prostate Specific Antigen Levels of Individuals Living in Rural Areas
Suleyman Demirel University
Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer
The First Affiliated Hospital with Nanjing Medical University
JR
Institut Mutualiste Montsouris
Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment
Xijing Hospital
Prognostic Study of Prostate Cancer Via Dynamic Change of PSA in Peritoneal Drainage Fluid After Radical Prostatectomy
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Prognostic Study of Via Dynamic Change of PCA3 mRNA in Drainage Fluid After Radical Prostatectomy
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Prognostic Study of Via Dynamic Change of dT-DNA in Drainage Fluid After Radical Prostatectomy
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
S3M-MRI
Karolinska Institutet
Comparison of Nerve-sparing Techniques in Radical Prostatectomy for Oncological Outcome and Functional Recovery.
The First Affiliated Hospital with Nanjing Medical University
PAX
Alberta Health services
A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients
RenJi Hospital
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study
Peking University Third Hospital
OLIGOMET
Medical University of Vienna
Analyzing Clinical Trial Experiences of Prostate Cancer Patients
Power Life Sciences Inc.
RADICALS-TR
University College, London
Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
Power Life Sciences Inc.
A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients
Power Life Sciences Inc.
An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer
Specialty Networks Research.